Functional genomics of brain development and developmentally related brain disease in "Drosophila"

One of the fundamental challenges in basic neuroscience is to understand the molecular genetic networks associated with building the brain. As malfunction in these genetic pathways can lead to disorders like cancer, brain development is also a crucial research area for clinical neuroscience. In the course of this thesis, different molecular aspects of Drosophila brain development and related neoplastic disease were analyzed using high-density oligonucleotide arrays. The homeotic selector gene labial (lab) plays an important role in specification of neuronal identity in the embryonic brain of Drosophila. In labial mutants presumptive neurons in the posterior tritocerebrum fail to differentiate. This leads to severe defects in tritocerebral axon pathways. Using high density oligonucleotide arrays we identified downstream target genes of Labial and showed that only a limited and distinct set of genes expressed in the embryo is regulated by this homeoprotein. Furthermore, we performed genetic rescue experiments to analyze the functional equivalence of Drosophila Hox gene products in specification of the tritocerebral neuromere. Surprisingly, all tested homeotic proteins, with the exception of Abd-B, were able to rescue the labial mutant phenotype in the tritocerebrum. These results indicate that the specificity of homeotic gene action in embryonic brain development has to be modulated by cis-acting regulatory elements. Another study circled around the homeobox transcription factor otd and its human homolog Otx2. Cross-phylum rescue experiments have shown that these genes are functionally equivalent. We used quantitative transcript imaging to analyze otd and Otx gene action in the Drosophila embryo at a genomic level. Our experiments suggest that about one third of the Otd-regulated transcripts in Drosophila can also be controlled by the human Otx2. These common otd/Otx2 downstream genes are likely to represent the molecular basis for the functional equivalence of otd and Otx2 gene action in Drosophila. glial cells missing (gcm) is a key control gene of gliogenesis. gcm loss-of-function leads to a transformation of glial cells into neurons and, conversely, when gcm is ectopically misexpressed, presumptive neurons become glia. Since gcm encodes a transcription factor it is supposed that a set of downstream genes are regulated by GCM that in turn execute the glial differentiation program. Again, a set of full-genome transcript profiling experiments was conducted to identify gcm downstream genes in a comprehensive manner. A set of several hundred candidate gcm target genes were identified in this screen, giving new insights into neuroglial fate specification in Drosophila. Brain tumors have been extensively studied by looking at genetic alterations and mutations that lead to malignant growth. Still, the causes of brain tumorigenesis are largely unknown. Model systems like Drosophila can be of great help to shed light on altered transcriptional activity in brain tumor phenotypes. To investigate the in vivo transcriptional activity associated with a brain tumor, we conducted genome-wide microarray expression analyses of an adult brain tumor in Drosophila caused by homozygous mutation in the tumor suppressor gene brain tumor (brat). Two independent gene expression studies using two different oligonucleotide microarray platforms were used to compare the transcriptome of adult wildtype flies with mutants displaying the adult bratk06028 mutant brain tumor. Cross-validation and stringent statistical criteria identified a core transcriptional signature of bratk06028 neoplastic tissue. We found highly significant expression level changes for 321 annotated genes associated with the adult neoplastic bratk06028 tissue indicating elevated and aberrant metabolic and cell cycle activity, upregulation of the basal transcriptional machinery, as well as elevated and aberrant activity of ribosome synthesis and translation control. One fifth of these genes show homology to known mammalian genes involved in cancer formation. These results identify for the first time the genome-wide transcriptional alterations associated with an adult brain tumor in Drosophila and reveal insights into the possible mechanisms of tumor formation caused by homozygous mutation of the translational repressor brat

Identification of candidate downstream genes for the homeodomain transcription factor Labial in Drosophila through oligonucleotide-array transcript imaging

BACKGROUND: Homeotic genes are key developmental regulators that are highly conserved throughout evolution. Their encoded homeoproteins function as transcription factors to control a wide range of developmental processes. Although much is known about homeodomain-DNA interactions, only a small number of genes acting downstream of homeoproteins have been identified. Here we use a functional genomic approach to identify candidate target genes of the Drosophila homeodomain transcription factor Labial. RESULTS: High-density oligonucleotide arrays with probe sets representing 1,513 identified and sequenced genes were used to analyze differential gene expression following labial overexpression in Drosophila embryos. We find significant expression level changes for 96 genes belonging to all functional classes represented on the array. In accordance with our experimental procedure, we expect that these genes are either direct or indirect targets of labial gene action. Among these genes, 48 were upregulated and 48 were downregulated following labial overexpression. This corresponds to 6.3% of the genes represented on the array. For a selection of these genes, we show that the data obtained with the oligonucleotide arrays are consistent with data obtained using quantitative RT-PCR. CONCLUSIONS: Our results identify a number of novel candidate downstream target genes for Labial, suggesting that this homeoprotein differentially regulates a limited and distinct set of embryonically expressed Drosophila genes

Evolutionary conservation of otd/Otx2 transcription factor action: a genome-wide microarray analysis in Drosophila

BACKGROUND: Homeobox genes of the orthodenticle (otd)/Otx family have conserved roles in the embryogenesis of head and brain. Gene replacement experiments show that the Drosophila otd gene and orthologous mammalian Otx genes are functionally equivalent, in that overexpression of either gene in null mutants of Drosophila or mouse can restore defects in cephalic and brain development. This suggests that otd and Otx genes control a comparable subset of downstream target genes in either organism. Here we use quantitative transcript imaging to analyze this equivalence of otd and Otx gene action at a genomic level. RESULTS: Oligonucleotide arrays representing 13,400 annotated Drosophila genes were used to study differential gene expression in flies in which either the Drosophila otd gene or the human Otx2 gene was overexpressed. Two hundred and eighty-seven identified transcripts showed highly significant changes in expression levels in response to otd overexpression, and 682 identified transcripts showed highly significant changes in expression levels in response to Otx2 overexpression. Among these, 93 showed differential expression changes following overexpression of either otd or Otx2, and for 90 of these, comparable changes were observed under both experimental conditions. We postulate that these transcripts are common downstream targets of the fly otd gene and the human Otx2 gene in Drosophila. CONCLUSION: Our experiments indicate that approximately one third of the otd-regulated transcripts also respond to overexpression of the human Otx2 gene in Drosophila. These common otd/Otx2 downstream genes are likely to represent the molecular basis of the functional equivalence of otd and Otx2 gene action in Drosophila

Transcriptional signature of an adult brain tumor in Drosophila.

BACKGROUND: Mutations and gene expression alterations in brain tumors have been extensively investigated, however the causes of brain tumorigenesis are largely unknown. Animal models are necessary to correlate altered transcriptional activity and tumor phenotype and to better understand how these alterations cause malignant growth. In order to gain insights into the in vivo transcriptional activity associated with a brain tumor, we carried out genome-wide microarray expression analyses of an adult brain tumor in Drosophila caused by homozygous mutation in the tumor suppressor gene brain tumor (brat). RESULTS: Two independent genome-wide gene expression studies using two different oligonucleotide microarray platforms were used to compare the transcriptome of adult wildtype flies with mutants displaying the adult bratk06028 mutant brain tumor. Cross-validation and stringent statistical criteria identified a core transcriptional signature of brat(k06028) neoplastic tissue. We find significant expression level changes for 321 annotated genes associated with the adult neoplastic brat(k06028) tissue indicating elevated and aberrant metabolic and cell cycle activity, upregulation of the basal transcriptional machinery, as well as elevated and aberrant activity of ribosome synthesis and translation control. One fifth of these genes show homology to known mammalian genes involved in cancer formation. CONCLUSION: Our results identify for the first time the genome-wide transcriptional alterations associated with an adult brain tumor in Drosophila and reveal insights into the possible mechanisms of tumor formation caused by homozygous mutation of the translational repressor brat.RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'. In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are

Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>Even the best cancer surgery is usually associated with minimal residual disease. Whether these remaining malignant cells develop into clinical recurrence is at least partially determined by adequacy of host defense, especially natural killer cell function. Anesthetics impair immune defenses to varying degrees, but nitrous oxide appears to be especially problematic. We therefore tested the hypothesis that colorectal-cancer recurrence risk is augmented by nitrous oxide administration during colorectal surgery.</p> <p>Methods</p> <p>We conducted a 4- to 8-year follow-up of 204 patients with colorectal cancer who were randomly assigned to 65% nitrous oxide (n = 97) or nitrogen (n = 107), balanced with isoflurane and remifentanil. The primary outcome was the time to cancer recurrence. Our primary analysis was a multivariable Cox-proportional-hazards regression model that included relevant baseline variables. In addition to treatment group, the model considered patient age, tumor grade, dissemination, adjacent organ invasion, vessel invasion, and the number of nodes involved. The study had 80% power to detect a 56% or greater reduction in recurrence rates (i.e., hazard ratio of 0.44 or less) at the 0.05 significance level.</p> <p>Results</p> <p>After adjusting for significant baseline covariables, risk of recurrence did not differ significantly for nitrous oxide and nitrogen, with a hazard ratio estimate (95% CI) of 1.10 (0.66, 1.83), <it>P </it>= 0.72. No two-way interactions with the treatment were statistically significant.</p> <p>Conclusion</p> <p>Colorectal-cancer recurrence risks were not greatly different in patients who were randomly assigned to 65% nitrous oxide or nitrogen during surgery. Our results may not support avoiding nitrous oxide use to prevent recurrence of colorectal cancer.</p> <p>Implications Statement</p> <p>The risk of colorectal cancer recurrence was similar in patients who were randomly assigned to 65% nitrous oxide or nitrogen during colorectal surgery.</p> <p>Trial Registration</p> <p>Current Controlled Clinical Trials NCT00781352 <url>http://www.clinicaltrials.gov</url></p

Promoting reuse behaviour: Challenges and strategies for repeat purchase, low-involvement products

Reusable products offer reduced environmental impact compared to recycling, but producers mostly focus on strategies such as light-weighting, recyclability and eco-labelling. A reasonable number of innovative reusable products and business models exist for repeat purchase, low-involvement products, but they are largely restricted to niche health-food stores. Therefore, this research primarily attempts to understand consumer attitudes and behaviour towards reuse of household care products (e.g. air fresheners, domestic cleaning products). Focus groups with UK consumers are utilised to examine reusable/refillable spray products and the data are triangulated with global archival data on various refill business models, reusable products and recycling initiatives. The study offers useful guidelines for both producers and policy makers to encourage reusable products. First, we recommend that eco-innovations have a familiar design congruent with well-known brands, to reduce uncertainties for consumers. Second, if the innovation has an unfamiliar design, to mitigate, producers should offer new functional benefits. Third, and most important, producers must place greater emphasis on aesthetic aspects that could evoke product attachment, thus encouraging reuse. Fourth, if reusable products are to become mainstream, ‘well-known brands’ have to promote the transition from one-off sales to a service model built on durable products. Finally, a successful outcome is dependent on government interventions in designing new life cycle policy instruments, in particular de-marketing the current recycling norm and emphasising reusing over recycling